PAHC
#2258
Phibro Animal Health Corporation - Class A Common Stock
33.7 4 USD
+0.02%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
+2.12%
Monthly Change
+6.30%
6 month change
-17.34%
Year Change
+10.48%
Previous Close
33.0 4
Open
33.7 4
Low
33.7 4
High
33.7 4
Volume
47
Financials
- Market Capitalization 1.37 B
- Employee 2 475
- Founded N/A
- CEO N/A
- Website www.pahc.com
- Headquarter Delaware, United States
- FIGI BBG000C31ZH2
- Industry Drug Manufacturers—Specialty & Generic
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
23.64
Price to sales ratio
1.51
Dividends per share
0.12
Dividend yield %
1.52
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 2148 |  HROW Harrow, Inc. - Common Stock | 42.93 USD | +3.77% | -4.32% | +10.90% | +10.08% | 1.60 B USD | ||
| 2237 |  PRGO Perrigo Company plc Ordinary Shares | 10.15 USD | +2.32% | -3.97% | -4.87% | -52.83% | 1.40 B USD | ||
| 2347 |  COLL Collegium Pharmaceutical, Inc. - Common Stock | 36.72 USD | +4.85% | +2.97% | +11.27% | +4.50% | 1.19 B USD | ||
| 2435 |  ALVO Alvotech - Ordinary Shares | 3.38 USD | +2.42% | -0.59% | -12.21% | -60.02% | 1.05 B USD |
Frequently asked questions about Phibro Animal Health Corporation - Class A Common Stock
What is the Phibro Animal Health Corporation - Class A Common Stock stock price today?
The current price of Phibro Animal Health Corporation - Class A Common Stock (PAHC) is 33.74. Over the past 24 hours, the stock has changed by +2.12%. Follow the PAHC chart for real-time price dynamics.
What is the stock ticker of Phibro Animal Health Corporation - Class A Common Stock?
Phibro Animal Health Corporation - Class A Common Stock trades under the ticker PAHC. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Phibro Animal Health Corporation - Class A Common Stock stock going up?
PAHC has changed by +3.91% over the last week, +6.30% over the last month, and +10.48% over the last year. Review the chart to see whether the current move is part of a broader trend.
Does Phibro Animal Health Corporation - Class A Common Stock release financial reports?
Yes. You can track Phibro Animal Health Corporation - Class A Common Stock financial reports and review yearly or quarterly fundamentals on metatrader.com, including revenue, net income, dividends, and valuation metrics.
What was Phibro Animal Health Corporation - Class A Common Stock net income for the last quarter?
Phibro Animal Health Corporation - Class A Common Stock reported net income of 24.02 M for the last quarter. The previous quarter showed 27.46 M, which means net income changed by -12.51%.
How many employees does Phibro Animal Health Corporation - Class A Common Stock have?
As of the latest available data, Phibro Animal Health Corporation - Class A Common Stock has 2 475 employees. Workforce size can provide additional context about the company's scale and operations.
What is Phibro Animal Health Corporation - Class A Common Stock EBITDA?
Phibro Animal Health Corporation - Class A Common Stock EBITDA is 55.25 M, and its EBITDA margin is 14.4%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Phibro Animal Health Corporation - Class A Common Stock stock?
You can buy Phibro Animal Health Corporation - Class A Common Stock (PAHC) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Phibro Animal Health Corporation - Class A Common Stock stock?
Investing in Phibro Animal Health Corporation - Class A Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the PAHC chart and related analysis on metatrader.com as part of your research.